Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Proscar

MagazineOctober 1996 (Vol. 7 Issue 7)Proscar

Proscar (finasteride) is making a return visit as our Drug of the Month, following some sensational revelations

Proscar (finasteride) is making a return visit as our Drug of the Month, following some sensational revelations. Manufactured by Merck, it has quickly established itself as the treatment of choice for benign enlarged prostate in the US and the UK.

But this has suddenly been thrown into question by a new study conducted by the University of Washington which shows that finasteride is no more effective than a sugar pill. Researchers tracked 1,229 patients, aged between 45 and 80, for a year to see if the drug was effective compared to terazosin, an alpha blocker, and a placebo. They found no difference between the finasteride and placebo groups, using quality of life measures.

The finding is contrary to an earlier trial which showed that the drug was very effective in reducing the prostate over a year. But the original trial apparently involved men with larger prostates, whereas those in the University of Washington survey had prostates of a size found more generally "in the real world," as research team leader Professor Michael Brawer put it to a conference recently.

All of this may be bad news for earlier finasteride patients who suffered from one of the side effects that come with the drug. These include impotence, reduced sexual interest, breast tenderness and enlargement, and hypersensitive reactions, such as lip swelling and skin rash.

These reactions have been observed among patients taking the standard, recommended dose of 5 mg a day. In tests on mice, death has occurred with single dosages of 1500 mg.

One piece of good news for prostate sufferers: the Washington study did find that terazosin was very effective in treating patients with prostates that had enlarged to a more usual size. Improvements were noted within two weeks.


Me caused by enzyme damage

Inhaled steroids stunt children's growth

You may also be interested in...

Sign up for free today

Sign up now to get your FREE 17-point Plan to Great Health

Free membership gives you access to our latest news reports, use of our community area, forums, blogs, readers' health tips and our twice-weekly
e-news letter.

WDDTY Recommends

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, cancer, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2016 WDDTY Publishing Ltd.
All Rights Reserved